Serving Size: 1 Capsule
Saccharomyces boulardii ATCC74352 … 250 mg (5,000,000,000 Organisms)
Non-medicinal ingredients: Capsule: hypromellose.
AOR Guarantees: that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, corn, nuts, dairy, eggs, fish, shellfish or any animal byproduct.
Source: Biological fermentation
What Is It?
Saccharomyces boulardii is a non-pathogenic, non-colonizing species of yeast.
What Does It Do?
Primary Uses: Saccharomyces boulardii is clinically recognized for its effectiveness in reducing the symptoms of antibiotic-associated diarrhea and Clostridium difficile infection, which can result from antibiotic use, hospitalization or traveling abroad. Saccharomyces boulardii significantly reduces both the risk and the duration of diarrhea. Saccharomyces boulardii has also been used to treat acute diarrhea or gastroenteritis in children.
Who Should Take It?
Saccharomyces boulardii is an excellent companion for those traveling abroad to reduce the risk of Traveler's diarrhea, is helpful for those experiencing antibiotic-associated diarrhea or acute diarrhea, or for anyone who has been hospitalized and treated with antibiotics.
Take three capsules per day in divided doses between meals.
Bleichner G, Blehaut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind, placebo-controlled trial. Intensive Care Med. 1997; 23:517-523.
Can M, et al. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit. 2006 Apr;12(4):PI19-22. Epub 2006 Mar 28.
Castagliuolo I, Riegler MF, Valenick L, et al. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun. 1999; 67:302-307.
Elmer GW, McFarland LV, Surawicz CM, et al. Behavior of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment Pharmacol Ther. 1999; 13:1663-1668.
McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis. 2007 Mar;5(2):97-105. Epub 2005 Dec 5.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.